ATE376827T1 - Solid darreichungsform enthaltend koffein - Google Patents

Solid darreichungsform enthaltend koffein

Info

Publication number
ATE376827T1
ATE376827T1 AT04255750T AT04255750T ATE376827T1 AT E376827 T1 ATE376827 T1 AT E376827T1 AT 04255750 T AT04255750 T AT 04255750T AT 04255750 T AT04255750 T AT 04255750T AT E376827 T1 ATE376827 T1 AT E376827T1
Authority
AT
Austria
Prior art keywords
solid pharmaceutical
caffeine
form containing
pharmaceutical form
containing caffeine
Prior art date
Application number
AT04255750T
Other languages
English (en)
Inventor
Indukumar G Shah
Christopher E Szymczak
Anthony A Osei
Karl J Pruss
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Application granted granted Critical
Publication of ATE376827T1 publication Critical patent/ATE376827T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04255750T 2003-09-23 2004-09-22 Solid darreichungsform enthaltend koffein ATE376827T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/671,138 US20050065172A1 (en) 2003-09-23 2003-09-23 Solid dosage form comprising caffeine

Publications (1)

Publication Number Publication Date
ATE376827T1 true ATE376827T1 (de) 2007-11-15

Family

ID=34194840

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04255750T ATE376827T1 (de) 2003-09-23 2004-09-22 Solid darreichungsform enthaltend koffein

Country Status (11)

Country Link
US (1) US20050065172A1 (de)
EP (1) EP1518551B1 (de)
KR (1) KR20050030157A (de)
CN (1) CN100441224C (de)
AT (1) ATE376827T1 (de)
CA (1) CA2482114C (de)
DE (1) DE602004009731T2 (de)
ES (1) ES2295787T3 (de)
MX (1) MXPA04009258A (de)
PL (1) PL1518551T3 (de)
PT (1) PT1518551E (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525029D0 (en) * 2005-12-08 2006-01-18 Univ Hull Receptor Antagonist
US20150209360A1 (en) * 2014-01-30 2015-07-30 Orbz, Llc Oral caffeine delivery composition
US20210274828A1 (en) * 2014-06-06 2021-09-09 Nicholas J. Singer Quick dissolve drinks and edibles and machine for manufacturing the same
WO2025012777A1 (en) * 2023-07-07 2025-01-16 Lyrus Life Sciences Pvt. Ltd. Taste masked granule composition of caffeine and its process of preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1287431A (en) * 1969-04-16 1972-08-31 Aspro Nicholas Ltd Improvements in pharmaceutical formulations
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
US4943565A (en) * 1986-09-15 1990-07-24 Bristol-Myers Squibb Company Analgesic tablet of aspirin and caffeine containing low-substituted hydroxypropyl cellulose
KR100243956B1 (ko) * 1991-09-06 2000-03-02 랄프 알. 팔로 트라마돌 물질 및 아세트아미노펜을 포함하는 통증 치료용 약제학적 조성물
ES2046097B1 (es) * 1991-10-28 1994-09-01 S A L V A T Lab Sa Procedimiento para preparar una composicion antidesmenorrea.
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US6020002A (en) * 1994-06-14 2000-02-01 Fuisz Technologies Ltd. Delivery of controlled-release system(s)
EP0839526A3 (de) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Festes pharmazeutisches Präparat mit schneller Auflösungs- oder Disintegrationeigenschaften
AU5822798A (en) * 1998-01-13 1999-08-02 Procter & Gamble Company, The A detergent granule with improved dissolution
GB9816899D0 (en) * 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
DE19931708A1 (de) * 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen

Also Published As

Publication number Publication date
MXPA04009258A (es) 2005-07-05
ES2295787T3 (es) 2008-04-16
EP1518551A1 (de) 2005-03-30
PT1518551E (pt) 2007-12-06
CN100441224C (zh) 2008-12-10
CA2482114C (en) 2011-12-13
DE602004009731D1 (de) 2007-12-13
EP1518551B1 (de) 2007-10-31
CA2482114A1 (en) 2005-03-23
KR20050030157A (ko) 2005-03-29
US20050065172A1 (en) 2005-03-24
DE602004009731T2 (de) 2008-08-28
PL1518551T3 (pl) 2008-03-31
CN1616103A (zh) 2005-05-18

Similar Documents

Publication Publication Date Title
DE60217367D1 (de) Nanopartikelzusammensetzungen enthaltend insulin
ES2191616T3 (es) Polvos pulverizables de fluoropolimeros no fibrilables.
UY38044A (es) Composiciones farmacéuticas sólidas que comprenden fenofibrato en nanopartículas
WO2003024396A3 (en) Dry powder medicament formulations
DE60234945D1 (de) Pulver zur nasalen verabreichung von wirkstoffen
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
NZ548351A (en) Direct compression formulation and process
WO2006085101A3 (en) Pharmaceutical compositions useful in the transmucosal administration of drugs
CY1107714T1 (el) Φαρμακευτικες συνθεσεις μοδαφινιλιου
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
EA200400045A1 (ru) Система для ингаляции сухим порошком для транспульмонарного применения
DK1553927T3 (da) Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
EP1458362A4 (de) Pharmazeutische zusammensetzungen in teilchenform
DK1196146T3 (da) Pulverpartikler med glat overflade til anvendelse i inhalationsterapi
BR0213608A (pt) Composição oral
DE69907717D1 (de) Pharmazeutische formulierung in form eines trockenen pulvers
DE60044245D1 (de) Herstellungsverfahren von ultrafeinen zinkoxidteilchen
IL169793A (en) Compounds containing antacids and antioxidants and using them for the preparation of a medicinal product
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
ATE376827T1 (de) Solid darreichungsform enthaltend koffein
WO2003090715A3 (en) Particulate materials
TR200504890T1 (tr) Benipidin hidroklorür içeren farmasötik bileşim
EA200500387A1 (ru) Композиции для ингаляции с высоким содержанием лекарственных веществ
BR0006736A (pt) Processo para aperfeiçoar a estabilidade de pelo menos um derivado de dibenzoilmetano diante da radiação uv e utilização de um filtro uv orgânico insolúvel sob a forma micronizada
MY121175A (en) Ciclesonide-containing aqueous pharmaceutical composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties